From lab to commercialization: Navigate the evolving risks of life science companies -
Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding...more
6/5/2025
/ Artificial Intelligence ,
Biotechnology ,
C-Suite Executives ,
Clinical Laboratories ,
Clinical Trials ,
Commercial Insurance Policies ,
Cyber Insurance ,
Early Stage Companies ,
Emerging Growth Companies ,
Initial Public Offering (IPO) ,
Insurance Industry ,
Life Sciences ,
Research and Development ,
Risk Management ,
Risk Mitigation ,
Webinars
Inflation—both economic and social—continues to contribute to premium increases in the P&C insurance market, and rising reinsurance costs due to severe weather events have led to higher property insurance costs. However, we...more
The road to commercializing a life sciences product is a long one, spanning years to perform research, develop the product, conduct clinical trials and testing, and receive approval from the Food and Drug Administration...more
Life sciences companies face unique exposures. Even within the various stages of research and development, the risks companies face change depending on their stage of development. With more than 500 clients in the life...more